- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
RON is not a prognostic marker for resectable pancreatic cancer ; volume:12 ; number:1 ; day:7 ; month:9 ; year:2012 ; pages:1-9 ; date:12.2012
BMC cancer ; 12, Heft 1 (7.9.2012), 1-9, 12.2012
- Beteiligte Personen und Organisationen
-
Tactacan, Carole M.
Chang, David K.
Cowley, Mark J.
Humphrey, Emily S.
Wu, Jianmin
Gill, Anthony J.
Chou, Angela
Nones, Katia
Grimmond, Sean M.
Sutherland, Robert L.
Biankin, Andrew V.
Daly, Roger J.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-12-395
- URN
-
urn:nbn:de:1111-201603044251
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tactacan, Carole M.
- Chang, David K.
- Cowley, Mark J.
- Humphrey, Emily S.
- Wu, Jianmin
- Gill, Anthony J.
- Chou, Angela
- Nones, Katia
- Grimmond, Sean M.
- Sutherland, Robert L.
- Biankin, Andrew V.
- Daly, Roger J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
The lipase/amylase ratio (LAR) in peripheral blood might represent a novel prognostic marker in patients with surgically resectable pancreatic cancer
Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study
Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
The lipase/amylase ratio (LAR) in peripheral blood might represent a novel prognostic marker in patients with surgically resectable pancreatic cancer
Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study
Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study
Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
The lipase/amylase ratio (LAR) in peripheral blood might represent a novel prognostic marker in patients with surgically resectable pancreatic cancer
Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study
Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor
Molecular biological characterisation of resectable pancreatic ductal adenocarcinoma
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
TWIST1 is a prognostic factor for neoadjuvant chemotherapy for patients with resectable pancreatic cancer: a preliminary study